Evaluation of API 20E strips for identification of coagulase-negative staphylococci from the urinary tract. 1983

D Y Anderson, and G N Vredeveld, and S R Brake, and T F Buchanan, and J F Lewis

A previous study indicated that the API 230E system can identify coagulase-negative Staphylococcus species. A study was devised to evaluate the use of the API 20E system for this purpose. Because of the current interest in Staphylococcus saprophyticus the relationship of the API 20E results to novobiocin susceptibility was also examined. One hundred forty-nine isolates of coagulase-negative staphylococci from urine cultures were tested with the API 20E system. The identification of 49 isolates was confirmed by Kloos and Schleifer method. We found that the routine API 20E system did not provide more information than novobiocin susceptibility studies alone, and that there was good but not absolute correlation between novobiocin resistance and identification of S. saprophyticus.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009675 Novobiocin An antibiotic compound derived from Streptomyces niveus. It has a chemical structure similar to coumarin. Novobiocin binds to DNA gyrase, and blocks adenosine triphosphatase (ATPase) activity. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p189) Crystallinic Acid,Streptonivicin,Novobiocin Calcium,Novobiocin Sodium,Novobiocin, Monosodium Salt,Calcium, Novobiocin,Monosodium Salt Novobiocin,Sodium, Novobiocin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001431 Bacteriological Techniques Techniques used in studying bacteria. Bacteriologic Technic,Bacteriologic Technics,Bacteriologic Techniques,Bacteriological Technique,Technic, Bacteriological,Technics, Bacteriological,Technique, Bacteriological,Techniques, Bacteriological,Bacteriologic Technique,Bacteriological Technic,Bacteriological Technics,Technic, Bacteriologic,Technics, Bacteriologic,Technique, Bacteriologic,Techniques, Bacteriologic
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D013210 Staphylococcus A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection

Related Publications

D Y Anderson, and G N Vredeveld, and S R Brake, and T F Buchanan, and J F Lewis
October 1978, Journal of clinical microbiology,
D Y Anderson, and G N Vredeveld, and S R Brake, and T F Buchanan, and J F Lewis
January 1986, American journal of clinical pathology,
D Y Anderson, and G N Vredeveld, and S R Brake, and T F Buchanan, and J F Lewis
November 1982, Journal of clinical microbiology,
D Y Anderson, and G N Vredeveld, and S R Brake, and T F Buchanan, and J F Lewis
September 1982, American journal of clinical pathology,
D Y Anderson, and G N Vredeveld, and S R Brake, and T F Buchanan, and J F Lewis
July 1983, The Indian journal of medical research,
D Y Anderson, and G N Vredeveld, and S R Brake, and T F Buchanan, and J F Lewis
February 1983, Journal of clinical microbiology,
D Y Anderson, and G N Vredeveld, and S R Brake, and T F Buchanan, and J F Lewis
August 1983, Journal of clinical microbiology,
D Y Anderson, and G N Vredeveld, and S R Brake, and T F Buchanan, and J F Lewis
August 1974, Lancet (London, England),
D Y Anderson, and G N Vredeveld, and S R Brake, and T F Buchanan, and J F Lewis
March 1964, Journal of clinical pathology,
D Y Anderson, and G N Vredeveld, and S R Brake, and T F Buchanan, and J F Lewis
January 1988, Journal of postgraduate medicine,
Copied contents to your clipboard!